Calmare Therapeutics (CTTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-1990 | 03-1990 | 12-1989 | 09-1989 | 06-1989 | |
| Sales | 412 | 272 | 248 | 113 | -506 |
| Cost of Goods | 1,203 | 137 | 91 | 87 | -77 |
| Gross Profit | -791 | 134 | 157 | 26 | 210 |
| Operating Expenses | -244 | 789 | 673 | 582 | -480 |
| Operating Income | -344 | -517 | -425 | -468 | -25 |
| Interest Expense | 0 | 0 | 0 | 0 | -15 |
| Other Income | -343 | -205 | -166 | 97 | 260 |
| Pre-tax Income | -687 | -722 | -591 | -371 | 249 |
| Income Tax | 1 | 3 | 5 | 5 | 8 |
| Net Income Continuous | -582 | -728 | -492 | -310 | 592 |
| Net Income Discontinuous | -306 | 0 | -45 | -140 | -1,330 |
| Net Income | $-888 | $-728 | $-537 | $-450 | $-738 |
| EPS Basic Total Ops | -0.18 | N/A | N/A | N/A | -0.16 |
| EPS Basic Continuous Ops | -0.12 | N/A | N/A | N/A | 0.12 |
| EPS Basic Discontinuous Ops | -0.06 | N/A | N/A | N/A | -0.28 |
| EPS Diluted Total Ops | -0.18 | N/A | N/A | N/A | -0.16 |
| EPS Diluted Continuous Ops | -0.12 | N/A | N/A | N/A | 0.12 |
| EPS Diluted Discontinuous Ops | -0.06 | N/A | N/A | N/A | -0.28 |
| EBITDA(a) | $-344 | $-517 | $-425 | $-468 | $-25 |